pargyline has been researched along with Bulimia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keck, PE | 1 |
| Vuckovic, A | 1 |
| Pope, HG | 1 |
| Nierenberg, AA | 1 |
| Gribble, GW | 1 |
| White, K | 1 |
1 trial available for pargyline and Bulimia
| Article | Year |
|---|---|
Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
Topics: Agoraphobia; Blood Pressure; Bulimia; Depressive Disorder; Humans; Mental Disorders; Monoamine Oxida | 1989 |